Laboratory monitoring of the clinical effects of low molecular weight heparins
- 31 December 1991
- journal article
- clinical trial
- Published by Elsevier in Thrombosis Research
- Vol. 61, 49-62
- https://doi.org/10.1016/0049-3848(91)90403-j
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Association between plasma levels of tissue plasminogen activator and postoperative deep vein thrombosis-influence of prophylaxis with a low molecular weight heparinThrombosis Research, 1990
- Oligosaccharide mapping of low-molecular-weight heparins: structure and activity differencesJournal of Medicinal Chemistry, 1990
- Chemical and Biological Heterogeneity in Low Molecular Weight Heparins: Implications for Clinical Use and StandardizationSeminars in Thrombosis and Hemostasis, 1989
- The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic system activationBlood, 1987
- Increased fibrinolytic activity after surgery induced by low dose heparinThrombosis Research, 1987
- Study on the mechanism of action of heparin and related substances on the fibrinolytic system: Relationsship between plasminogen activators and heparinThrombosis Research, 1986
- Binding and endocytosis of heparin by human endothelial cells in cultureBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1985
- Molecular Markers of Hemostatic Activation: Future PerspectivesSeminars in Thrombosis and Hemostasis, 1984
- Heparin and a low molecular weight fraction enhances thrombolysis and by this pathway exercises a protective effect against thrombosisThrombosis Research, 1983
- The Thromboplastin Generation TestJournal of Clinical Pathology, 1953